William Blair Analysts Increase Earnings Estimates for Portola Pharmaceuticals Inc (NASDAQ:PTLA)
-
Summary:
Portola Pharmaceuticals Inc (NASDAQ:PTLA) – William Blair upped their FY2019 earnings per share estimates for shares of Portola Pharmaceuticals in a report issued on Wednesday, November 6th, according to Zacks Investment Research. William Blair analyst M. Phipps now anticipates that the biopharmaceutical company will earn ($2.93) per share for the year, up from their prior forecast of ($3.59). William Blair has a “Buy” rating on the stock. William Blair also issued estimates for Portola Pharmaceuticals’ Q4 2019 earnings at ($0.47) EPS, Q1 2020 earnings at ($0.57) EPS, Q2 2020 earnings at ($0.51) EPS, Q3 2020 earnings at ($0.42) EPS, Q4 2020 earnings at ($0.34) EPS, FY2020 earnings at ($1.84) EPS, FY2021 earnings at ($0.69) EPS and FY2022 earnings at $1.15 EPS.
Portola Pharmaceuticals ...
